About the conference
For the 8th time, the Helmholtz Zentrum München is organizing this high-impact conference series. Internationally leading scientists in diabetes research are joining us here in Munich to present and discuss their most recent data and achievements during this event. Our overriding goal is to find new ways for the prevention and treatment of type 1 and type 2 diabetes. This conference will focus on the genetic and epigenetic mechanisms involved in the development of diabetes. The world’s leading faculty in this area will thus enrich this year’s program. Following our long-standing tradition, we will feature again the HelDI (Helmholtz Young Investigator in Diabetes) competition with selected talks by rising stars in the field of diabetes, and the presentation of the Helmholtz Diabetes Lecture. In 2021, Susan Bonner-Weir (Harvard University) will receive this award in recognition of her life-time achievements.
Helmholtz Zentrum München
Helmholtz Zentrum München, the German Research Center for Environmental Health, develops efficient methods for the early detection, prevention, diagnosis and treatment of important common diseases that arise from the interaction between the environment and individual genetic backgrounds. One major focus of the Center is on diabetes.